rEGU 33 OF SEBI(LODR)2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Unjha Formulations Ltd has filed a disclosure under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the submission of standalone and/or consolidated financial results. The specific headline provided does not include the actual financial figures, period covered, or detailed numbers. Reg 33 filings are mandatory quarterly/annual results submissions made to the stock exchanges after approval by the company's Board of Directors. Shareholders should refer to the full financial result document for exact revenue, profit, and other key metrics.
The filing itself is a routine compliance disclosure and does not by itself indicate positive or negative business performance. Investors should look at the actual financial numbers in the full result document to assess the company's quarterly performance and any impact on the stock.